Shandong Weigao boosts treasury holdings with latest share repurchase

Shandong Weigao Group Medical Polymer Company Limited disclosed a share repurchase on October 20, 2025. The company bought back 249,600 H-shares on the Exchange at a volume-weighted average price of HK$5.6028 per share, totaling an aggregate cost of HK$1,398,456. The highest price paid was HK$5.61, and the lowest was HK$5.6.

This repurchase increased treasury shares by 249,600, raising the total from 21,842,000 to 22,091,600. Consequently, the number of issued shares, excluding treasury shares, decreased from 4,500,490,324 to 4,500,240,724. This transaction represents 0.0055% of the existing issued shares before the event.

The company's mandate to repurchase shares, granted on May 27, 2025, authorized the repurchase of up to 451,560,392 shares. With this latest transaction, 15,443,200 shares have been repurchased under the mandate, representing 3.42% of the issued shares as of the mandate's grant date. A moratorium period for new share issues or treasury share sales is in effect until November 19, 2025.